1207. Deputy Peadar Tóibín asked the Minister for Health the amount spent by the HSE and each CHO region on leasing and renting properties in each county in the state in each of the past five years; and to provide a list of all such properties and the annual cost associated with each. [64667/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
1,180 questions match, newest first.
1208. Deputy Peadar Tóibín asked the Minister for Health the amount spent by the HSE and Saolta University Health Care Group on leasing and renting properties in Donegal, Sligo and Leitrim in each of the past five years; and to provide a list of all such properties and the annual cost associated with each. [64666/26]
1209. Deputy Peadar Tóibín asked the Minister for Health whether the payment of the €645,000 Data Protection Commission fine will impact any health service budget, staffing allocation or capital project. [64675/26]
1211. Deputy Peadar Tóibín asked the Minister for Health whether a national audit has been carried out of HSE facilities used to store patient records; and whether any deficiencies have been identified. [64673/26]
1223. Deputy Conor D. McGuinness asked the Minister for Health when a person (details supplied) will be reimbursed under the Cross Border Directive; and if she will make a statement on the matter. [64707/26]
1224. Deputy Niamh Smyth asked the Minister for Health If she will review the case of a person (details supplied); if she will provide an update on the spinal cord stimulator procedure scheduled at St Vincent's University Hospital; if she will address the cancellation of the procedure on two separate occasions, the most recent on financial grounds; to confirm the meaning of 'financial constraints' in this context; an…
1225. Deputy Michael Cahill asked the Minister for Health to address a case (details supplied) and provide a full detailed care plan; and if she will make a statement on the matter. [64715/26]
1226. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2902 of 14 April 2026, whether the HSE currently holds a comparable measure of agency savings across all HSE regions; and if not, the date by which such a measure will be in place. [64767/26]
1227. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2902 of 14 April 2026, the total HSE agency spend to the most recent available date in 2026, set against the €720 million ceiling in the National Service Plan 2026, broken down by HSE region; and whether the HSE is currently on profile to meet that ceiling. [64766/26]
1228. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2902 of 14 April 2026, the number of occasions on which each of Tiers 1 to 4 of the Performance and Accountability Framework escalation process has been invoked in relation to agency staffing controls to date in 2026, broken down by HSE region. [64765/26]
1229. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2902 of 14 April 2026, if any non-compliance with agency staffing controls has been identified across the HSE to date in 2026; and if so, the number of instances identified, broken down by HSE region. [64764/26]
1230. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Questions 57689/26 and 57690/26, given that there is no entry on the National Incident Management System relating to the ambulance service or ambulance allocation, the mechanism used to record and count patient harm arising from delayed ambulance allocation; and if she intends to establish such a field within the National Incident Managem…
1231. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question 57690/26, which did not provide the yes or no requested, whether delayed ambulance allocation is a recordable category or field within the National Incident Management System; and to state yes or no. [64762/26]
1232. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question 57688/26, which did not provide the yes or no requested, whether delayed ambulance allocation is a specified trigger for review under the HSE Incident Management Framework; and to state yes or no. [64761/26]
1233. Deputy Niamh Smyth asked the Minister for Health if she will review the case of a person (details supplied); if she will provide an update on the home care package; and the reason the hours awarded have not been fully delivered. [64760/26]
1234. Deputy Ken O'Flynn asked the Minister for Health further to PQ 42510/26, whether any official within her Department, as distinct from the HSE, holds responsibility for determining whether procedures funded under the treatment abroad scheme should be subject to national clinical audit or outcome monitoring; and if she will make a statement on the matter. [64755/26]
1235. Deputy Ken O'Flynn asked the Minister for Health the mechanism by which the HSE verifies that an overseas provider is a public healthcare service, as distinct from a private provider, prior to authorisation under the treatment abroad scheme; whether that verification is conducted centrally or relies on the referring consultant; and if she will make a statement on the matter. [64754/26]
1236. Deputy Ken O'Flynn asked the Minister for Health the number and total value of invoices under the treatment abroad scheme in each of the past three years where the final invoice exceeded the pre-authorisation estimate by 25% or more; the number of those cases in which payment was queried, reduced or withheld; and if she will make a statement on the matter. [64753/26]
1237. Deputy Colm Burke asked the Minister for Health to confirm that funding has been set aside both in respect of the capital cost, commissioning and recruitment of the required number of staff in order to proceed with the development of a stem cell transplantation and advanced cellular therapies unit in Cork University Hospital; and if she will make a statement on the matter. [64736/26]
1238. Deputy Ken O'Flynn asked the Minister for Health the name, grade and unit of the official within her Department, and separately within the HSE, who holds responsibility for clinical, as distinct from financial, outcome monitoring of procedures funded under the treatment abroad scheme; and if she will make a statement on the matter. [64752/26]
1241. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any record of clinical outcomes, including complications, readmissions or mortality, for patients treated under the treatment abroad scheme; if so, to provide those data in tabular form for each of the past five years; and if she will make a statement on the matter. [64751/26]
1242. Deputy Ken O'Flynn asked the Minister for Health the number of referrals under the treatment abroad scheme in each of the past five years that have been suspended, restricted, reviewed or escalated on grounds of clinical outcome, standard of care or patient safety, as distinct from cost or eligibility; and if she will make a statement on the matter. [64750/26]
1244. Deputy Seán Ó Fearghaíl asked the Minister for Health Ireland's position in EU negotiations on the proposed introduction of maximum permitted levels for vitamins and minerals in food supplements and whether Ireland will seek to defer any agreement on such levels until the most up-to-date scientific evidence has been assessed. [64731/26]
1245. Deputy Michael Cahill asked the Minister for Health the status of the roll out of Skyclarys (omaveloxolone) for patients with Friedreich's ataxia; the reason for delays following re-imbursement approval; when eligible patients can expect to access the treatment; and if she will make a statement on the matter. [64785/26]
1246. Deputy Eoin Ó Broin asked the Minister for Health for an update on an application for pricing and reimbursement (details supplied); if engagement with clinicians, patient organisations and other stakeholders has taken place, or is intended; and if timely access to this drug will be ensured for those who require it. [64800/26]